1852 A phase II trial of docetaxel plus carboplatin plus bevacizumab as neoadjuvant therapy for triple negative breast cancer by Chacón López-Muñiz, J.I, Cárdenas, J.D, Santos Rodríguez, A.K, Esteban Esteban, M.C, Muñoz Platón, E, Rubio Salvador, A.R, Alonso Soler, S.E, Fernández Franco, L, San Juan del Moral, A, Burgueño Lorenzo, I, Trujillo Alba, B.L, Martínez Moreno, E, Moya Gómez, P, Cruz Mora, M.A

Get full text